| The concise guide to pharmacology 2019/20: Enzymes SPH Alexander, D Fabbro, E Kelly, A Mathie, JA Peters, EL Veale, ... British Journal of Pharmacology 176, S297-S396, 2019 | 542 | 2019 |
| The concise guide to pharmacology 2021/22: Enzymes SPH Alexander, D Fabbro, E Kelly, A Mathie, JA Peters, EL Veale, ... British journal of pharmacology 178, S313-S411, 2021 | 381 | 2021 |
| Adenosine signaling and function in glial cells D Boison, JF Chen, BB Fredholm Cell Death & Differentiation 17 (7), 1071-1082, 2010 | 374 | 2010 |
| Arousal effect of caffeine depends on adenosine A2A receptors in the shell of the nucleus accumbens M Lazarus, HY Shen, Y Cherasse, WM Qu, ZL Huang, CE Bass, ... Journal of Neuroscience 31 (27), 10067-10075, 2011 | 369 | 2011 |
| A ketogenic diet suppresses seizures in mice through adenosine A1 receptors SA Masino, T Li, P Theofilas, US Sandau, DN Ruskin, BB Fredholm, ... The Journal of clinical investigation 121 (7), 2679-2683, 2011 | 329 | 2011 |
| Adenosine kinase: exploitation for therapeutic gain D Boison, SPH Alexander Pharmacological reviews 65 (3), 906-943, 2013 | 328 | 2013 |
| The concise guide to pharmacology 2017/18: overview SPH Alexander, E Kelly, NV Marrion, JA Peters, E Faccenda, SD Harding, ... British journal of pharmacology 174, S1-S16, 2017 | 316 | 2017 |
| New insights into the mechanisms of the ketogenic diet D Boison Current opinion in neurology 30 (2), 187-192, 2017 | 312 | 2017 |
| Adenosine kinase, epilepsy and stroke: mechanisms and therapies D Boison Trends in pharmacological sciences 27 (12), 652-658, 2006 | 283 | 2006 |
| Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis RL Williams-Karnesky, US Sandau, TA Lusardi, NK Lytle, JM Farrell, ... The Journal of clinical investigation 123 (8), 3552-3563, 2013 | 282 | 2013 |
| Commonalities in epileptogenic processes from different acute brain insults: Do they translate? P Klein, R Dingledine, E Aronica, C Bernard, I Blümcke, D Boison, ... Epilepsia 59 (1), 37-66, 2018 | 279 | 2018 |
| Adenosine metabolism: emerging concepts for cancer therapy D Boison, GG Yegutkin Cancer cell 36 (6), 582-596, 2019 | 278 | 2019 |
| The adenosine kinase hypothesis of epileptogenesis D Boison Progress in neurobiology 84 (3), 249-262, 2008 | 276 | 2008 |
| Adenosine as a neuromodulator in neurological diseases D Boison Current opinion in pharmacology 8 (1), 2-7, 2008 | 275 | 2008 |
| Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice T Li, G Ren, T Lusardi, A Wilz, JQ Lan, T Iwasato, S Itohara, RP Simon, ... The Journal of clinical investigation 118 (2), 571-582, 2008 | 274 | 2008 |
| Disruption of the compacted myelin sheath of axons of the central nervous system in proteolipid protein-deficient mice. D Boison, W Stoffel Proceedings of the National Academy of Sciences 91 (24), 11709-11713, 1994 | 269 | 1994 |
| Adenosine and epilepsy: from therapeutic rationale to new therapeutic strategies D Boison The neuroscientist 11 (1), 25-36, 2005 | 268 | 2005 |
| Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis N Gouder, L Scheurer, JM Fritschy, D Boison Journal of Neuroscience 24 (3), 692-701, 2004 | 250 | 2004 |
| The concise guide to PHARMACOLOGY 2015/16: Overview SPH Alexander, E Kelly, N Marrion, JA Peters, HE Benson, E Faccenda, ... British journal of pharmacology 172 (24), 5729-5743, 2015 | 244 | 2015 |
| Neonatal hepatic steatosis by disruption of the adenosine kinase gene D Boison, L Scheurer, V Zumsteg, T Rülicke, P Litynski, B Fowler, ... Proceedings of the National Academy of Sciences 99 (10), 6985-6990, 2002 | 242 | 2002 |
